Letters

Ditta Bartels' view that the Victorian government's Infertility (Medical Procedures) Act of 1984 is the correct model for regulating in vitro fertilization (IVF) (The Scientist, April 6, 1987, p. 11) is not an opinion that is necessarily widely shared. Even the Attorney General of Victoria who prepared the legislation told Time Australia (March 23rd, 1987) that embryo experimentation "raises the very fundamental question that some things are better left unsaid. I'm not saying that I espouse that

Written byAlan Trounson
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

The committee formed to evaluate and advise on matters relating to the Act, including any proposed research, has unanimously supported the proposed research referred to by Bartels as "attempts to combat male infertility by injecting dysfunctional sperm into ripe eggs" and the Victoria government has responded by introducing an amendment to the Act to enable this research to be done. The governor of the state has also been critical of legislation that seeks to prevent research in this area. Indeed, I believe that the criminal penalties of fines and imprisonment attached to failure to comply with the rather ill-defined and widely interpreted sections of the Act probably have very little support in the general community. It certainly is difficult to equate these penalties for destruction of pre-implantation embryos (for whatever reason or misinterpretation) with the acceptance in Australia of abortion and some methods of contraception.

It isn't unusual in science ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies